Basic Information
RNALocate ID: | RLID:11004098 |
RNA Symbol: | hsa-miR-298 |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-298 |
RNA ID: | miRBase:MIMAT0004901 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24460325 |
Tissue/Cell Line: | K562 cells |
Method: | Microarray |
Description: | Cluster analysis arranged samples and miRNAs into groups based on their expression levels, which allowed us to hypothesize the relationships between miRNAs and samples. Interestingly, 49 miRNAs were up regulated in exosomes as compared to K562 cells (Table 1), with both P-value of <= 0.05 and more than 1.5-fold changes. Data are collected from Table 1. Differentially Expressed miRNAs Between Exosomes and K562 Cells. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11004097 | Exosome | Serum | 18589210 |
RLID-D:11001584 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
RLID-D:11004104 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-298 | Lymphoma | MNDR-E-MI-34430 |
MNDR | hsa-miR-298 | Estrogen-receptor positive breast cancer | MNDR-E-MI-34431 |
MNDR | hsa-miR-298 | Estrogen-receptor negative breast cancer | MNDR-E-MI-34432 |
MNDR | hsa-miR-298 | Progesterone-receptor positive breast cancer | MNDR-E-MI-34433 |
MNDR | hsa-miR-298 | Progesterone-receptor negative breast cancer | MNDR-E-MI-34434 |
MNDR | hsa-miR-298 | Her2-receptor positive breast cancer | MNDR-E-MI-34435 |
MNDR | hsa-miR-298 | Breast cancer luminal | MNDR-E-MI-34436 |
MNDR | hsa-miR-298 | Gastric cancer | MNDR-E-MI-34437 |
MNDR | hsa-miR-298 | Alzheimer disease | MNDR-E-MI-34438 |
MNDR | hsa-miR-298 | Intracranial aneurysm | MNDR-E-MI-34439 |
MNDR | hsa-miR-298 | Lung cancer | MNDR-E-MI-34440 |
MNDR | hsa-miR-298 | Parkinson disease | MNDR-E-MI-34441 |
MNDR | hsa-miR-298 | Basal-like breast cancer | MNDR-E-MI-34442 |
MNDR | hsa-mir-298 | Breast cancer | MNDR-E-MI-34443 |
MNDR | hsa-miR-298 | Thyroid cancer | MNDR-E-MI-34444 |
MNDR | hsa-miR-298 | Pancreatic cancer | MNDR-E-MI-34445 |
MNDR | hsa-miR-298 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-34446 |
MNDR | hsa-miR-298 | Familial ovarian cancer | MNDR-E-MI-34447 |
MNDR | hsa-miR-298 | Glioblastoma | MNDR-E-MI-34448 |
MNDR | hsa-miR-298 | Meningioma | MNDR-E-MI-34449 |
MNDR | hsa-miR-298 | Lung adenocarcinoma | MNDR-E-MI-34450 |
MNDR | hsa-miR-298 | Biliary tract cancer | MNDR-E-MI-34451 |
MNDR | hsa-miR-298 | Cholangiocarcinoma | MNDR-E-MI-34452 |
MNDR | hsa-miR-298 | Hepatocellular carcinoma | MNDR-E-MI-34453 |
MNDR | hsa-mir-298 | Hepatocellular carcinoma | MNDR-E-MI-34454 |
MNDR | hsa-miR-298 | Familiar ovarian carcinoma | MNDR-E-MI-34455 |
MNDR | hsa-miR-298 | Hodgkin lymphoma | MNDR-E-MI-34456 |
MNDR | hsa-mir-298 | Thrombocytopenic purpurea autoimmune | MNDR-E-MI-34457 |
MNDR | hsa-mir-298 | Systemic lupus erythematosus | MNDR-E-MI-34458 |
MNDR | hsa-miR-298 | Colorectal cancer | MNDR-E-MI-34459 |
MNDR | hsa-miR-298 | Nasopharynx carcinoma | MNDR-E-MI-34460 |
MNDR | hsa-mir-298 | Cerebral hemorrhage | MNDR-E-MI-34461 |
MNDR | hsa-miR-298 | Nasopharyngeal cancer | MNDR-E-MI-34462 |
MNDR | hsa-mir-298 | Stroke | MNDR-E-MI-34463 |
MNDR | hsa-miR-298 | Breast cancer her3+ negative | MNDR-E-MI-34464 |
MNDR | hsa-mir-298 | Systemic lupus erythematosus susceptibility | MNDR-E-MI-34465 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BACE1 | Homo sapiens | RR00209216 |
TOP